Bringing the Oncology Trial to the Patient: New Perspectives and Technologies That Enable More Engaging Trial Participation, Upcoming Webinar Hosted by Xtalks

In this free webinar, attendees will learn how patient diversity and equity can be improved through a hybrid decentralized clinical trial (DCT) approach and how to incorporate DCT methodologies into clinical trials. The featured speakers will also discuss how to adapt this approach to studies involving pediatric and elderly patients.

News provided by

Xtalks

Dec 14, 2021, 08:30 ET


TORONTO, Dec. 14, 2021 /PRNewswire-PRWeb/ -- The growing use of decentralized clinical trials (DCTs) has enabled greater patient engagement and driven diversity in trials by reducing the need for participants to frequently travel to investigator sites. While the unique needs of oncology trials might have initially made it seem a DCT approach doesn't apply, there is now a growing consensus that there is a benefit to using a hybrid approach to DCTs, where patients go to investigator sites when absolutely required, but participate remotely for those aspects of the trial where it is feasible to do so.

In this webinar, featured speakers will discuss the incorporation of DCT methodologies into clinical trials including:

  •     Where do we start? At what point in trial design does the impact of DCTs need to be factored in?
  •     What remote data collection methodologies and other DCT services are appropriate for oncology, and what are the regulatory implications of using them?
  •     How can patient diversity and equity be improved through a hybrid DCT approach?
  •     Special considerations for pediatric trials and those involving elderly participants

Register for this webinar in which a panel of speakers will answer these and other questions to raise awareness and prompt continued development of patient-centric trial designs.

Join expert speakers from Labcorp Drug Development, Kathleen Griffin (Moderator), VP, DCT Strategy & Enablement; Melissa Harris, Director, Patient Recruitment & Engagement, Global Patient Engagement; Jennifer Urwongse, Associate Director, Commercial Strategy, Decentralized Clinical Trials; and Begoña de las Heras Garcia, Senior Medical Director, Oncology MedSci, Oncology Global Clinical Development, for the live webinar on Tuesday, January 11, 2022 at 10am EST (4pm GMT/UK).

For more information, or to register for this event, visit Bringing the Oncology Trial to the Patient: New Perspectives and Technologies That Enable More Engaging Trial Participation.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Sydney Perelmutter, Xtalks, +1 (416) 977-6555 x 352, [email protected]

SOURCE Xtalks